Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,030 | 6,073 | 6,538 | 6,285 | 8,463 |
| Operating Income | -4,030 | -6,073 | -6,538 | -6,285 | -8,463 |
| Interest Expense | 3 | 5 | 12 | 5 | 5 |
| Other Income | 25 | 32 | 122 | 35 | 102 |
| Pre-tax Income | -4,008 | -6,046 | -6,428 | -6,255 | -8,366 |
| Income Tax | 3 | 8 | 5 | 5 | N/A |
| Net Income Continuous | -4,011 | -6,054 | -6,433 | -6,260 | -8,366 |
| Net Income | $-4,011 | $-6,054 | $-6,433 | $-6,260 | $-8,366 |
| EPS Basic Total Ops | -0.06 | -0.12 | -0.13 | -0.14 | -0.25 |
| EPS Basic Continuous Ops | -0.06 | -0.12 | -0.13 | -0.15 | -0.25 |
| EPS Diluted Total Ops | -0.06 | -0.12 | -0.13 | -0.14 | -0.25 |
| EPS Diluted Continuous Ops | -0.06 | -0.12 | -0.13 | -0.15 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.12 | -0.13 | -0.15 | -0.25 |
| EBITDA(a) | $-4,030 | $-6,073 | $-6,538 | $-6,285 | $-8,463 |